Webinars » Comprehensive Solutions for Advanced mRNA Manufacturing in RNA-Based Therape
In vitro transcribed (IVT) mRNA has emerged as a powerful therapeutic and preventive modality that can offer solutions for infectious diseases, cancer, monogenic disorders, and more. Some critical advantages of IVT mRNA as a therapeutic and prophylactic modality include; ①efficiency- rapid translation within the cytosol, facilitates and expedites protein expression, ②safety- no genomic integration risk, eliminates the chance of insertional mutagenesis and ③versatilitycell cycle independent transient expression of various protein types, such as intracellular, secreted, and receptors. Advances in mRNA synthesis methods and optimized purification processes have unlocked these advantages to fasten therapeutic development workflows and deliver safe and effective mRNA drugs.
During the webinar, we will start with introducing our IVT mRNA service and share our customer’s experience. There will also be discussions on how to apply our service into some applications.
Field Application Scientist, APAC region
Dr. Yerim Kwon joined GenScript in October 2023 as a Field Application Scientist, focusing on molecular biology, mRNA, and gene editing services. During her doctoral and postdoctoral research, she specialized in studying gene regulation pathways in response to environmental stress and RNA silencing. Her experience includes investigating RNA stability factors and post-translational regulation of RNA silencing pathways. Now, at GenScript, she applies her expertise to provide top-notch service to our clients.